Can I stop taking ensidipine after taking it for two months?

Enasidenib(Enasidenib) is a drug that targets proteins in cancer cells and stops them from growing. For the treatment of acute myelogenous leukemia. The use and discontinuation of ensidipine should be decided by a professional physician based on the patient's specific situation. Generally, the treatment time and discontinuation time are determined based on the patient's disease status and treatment effect.

Ensidipine, a small molecule inhibitor of mutated IDH2, has been reported to have an overall efficacy rate of 40.3% in relapsed or refractory disease, with 19.3% of patients achieving complete remission at the approved daily oral dose of 100 mg. After taking ensidipine for two months, if the patient's condition improves significantly, the doctor may consider gradually reducing the dose or discontinuing the drug based on the stability of the condition and the patient's overall condition. However, if the patient does not develop drug resistance or intolerance while taking ensidipine, it is generally not recommended to discontinue the drug at will. Because stopping the medication at will may affect the treatment effect and even cause the condition to worsen.

Encidipine research medicine is not currently on the market in China, so it cannot be included in medical insurance. The price of ensidipine plain medicine when it is launched overseas is very high, and the price of each box may be around 30,000 yuan (the price may fluctuate due to the exchange rate). Currently, there are cheaper generic ensidipine drugs produced by other pharmaceutical companies overseas. For example, the price of Specification50mg*30 tablets produced by a Laos pharmaceutical factory may be more than 2,000 yuan per box (the price may fluctuate due to the exchange rate). Its pharmaceutical ingredients are basically the same as those of the original drugs sold abroad. For more information on overseas drug prices and specific information, please consult Yaode Medical Consultant.